EKSO BIONICS HOLDINGS, INC.EKSOEarnings & Financial Report
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis (MS) or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Revenue
$5.0M
Gross Profit
$2.6M
Operating Profit
$-2.3M
Net Profit
$-2.4M
Gross Margin
53.3%
Operating Margin
-47.2%
Net Margin
-48.8%
YoY Growth
5.3%
EPS
$-1.99
EKSO BIONICS HOLDINGS, INC. Q2 FY2024 Financial Summary
EKSO BIONICS HOLDINGS, INC. reported revenue of $5.0M (up 5.3% YoY) for Q2 FY2024, with a net profit of $-2.4M (up 42.9% YoY) (-48.8% margin). Cost of goods sold was $2.3M, operating expenses totaled $5.0M.
Key Financial Metrics
| Total Revenue | $5.0M |
|---|---|
| Net Profit | $-2.4M |
| Gross Margin | 53.3% |
| Operating Margin | -47.2% |
| Report Period | Q2 FY2024 |
Revenue Breakdown
EKSO BIONICS HOLDINGS, INC. Q2 FY2024 revenue of $5.0M breaks down across 2 segments, led by Ekso Health at $4.8M (96.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Ekso Health | $4.8M | 96.6% |
| Other | $166.0K | 3.4% |
EKSO BIONICS HOLDINGS, INC. Revenue by Segment — Quarterly Trend
EKSO BIONICS HOLDINGS, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Ekso Health and Other) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Other | $799.0K | $986.0K | $885.0K | $888.0K |
EKSO BIONICS HOLDINGS, INC. Annual Revenue by Year
EKSO BIONICS HOLDINGS, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $12.8M).
| Year | Annual Revenue |
|---|---|
| 2025 | $12.8M |
| 2024 | $17.9M |
| 2023 | $18.3M |
| 2022 | $12.9M |
EKSO BIONICS HOLDINGS, INC. Quarterly Revenue & Net Profit History
EKSO BIONICS HOLDINGS, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $3.1M | -38.3% | $-4.7M | -148.9% |
| Q3 FY2025 | $4.2M | +2.4% | $-1.4M | -33.6% |
| Q2 FY2025 | $2.1M | -58.4% | $-2.7M | -131.7% |
| Q1 FY2025 | $3.4M | -10.1% | $-2.9M | -85.7% |
| Q4 FY2024 | $5.1M | +5.0% | $-3.4M | -67.1% |
| Q3 FY2024 | $4.1M | -10.4% | $-2.1M | -50.2% |
| Q2 FY2024 | $5.0M | +5.3% | $-2.4M | -48.8% |
| Q1 FY2024 | $3.8M | -8.9% | $-3.4M | -91.3% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M | $5.0M | $4.1M | $5.1M | $3.4M | $2.1M | $4.2M | $3.1M |
| YoY Growth | -8.9% | 5.3% | -10.4% | 5.0% | -10.1% | -58.4% | 2.4% | -38.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $29.0M | $27.0M | $29.2M | $26.7M | $27.3M | $23.2M | $21.7M | $20.1M |
| Liabilities | $14.9M | $14.9M | $14.3M | $13.9M | $14.6M | $12.2M | $12.0M | $11.1M |
| Equity | $14.1M | $12.1M | $14.9M | $12.7M | $12.7M | $10.9M | $9.7M | $9.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-3.5M | $-2.7M | $-2.3M | $-1.4M | $-2.0M | $-3.4M | $-2.1M | $-4.3M |